Author: Dr. Jia Li (Lily) Liu, Internal Medicine PGY-2, McGill UniversityExpert Reviewer: Dr. Gizelle Popradi, MD, Assistant Professor, Department of Medicine, Division of Hematology, McGill UniversityAfter completion of this self-assessment module, the learner will be able to:Understand how to diagnose Chronic Lymphocytic Leukemia (CLL). ...
Author: Julia Pennell MSc, MD, PGY2 Memorial UniversityExpert reviewer: Dr. Brian Harnett MD FRCPC, Clinical Assistant Professor, Memorial UniversityAccreditation: This activity is an Accredited Group Learning Activity (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons...
Author: Dr. Roslyn Mainland, PGY-2 Internal Medicine, Queen’s UniversityExpert reviewer: Dr. Paula James, MD, FRCP, Division of Hematology, Queen’s UniversityAccreditation: This activity is an Accredited Group Learning Activity (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and...
Author: Dr. Jia Li (Lily) Liu, Internal Medicine PGY-2, McGill University Reviewer: Dr. Kelly Davison, MD, PhD, Assistant Professor, Department of Medicine, McGill UniversityAfter completion of this self-assessment module, the learner will be able to: 1. Describe the staging system for Hodgkin Lymphoma. 2. Describe favourable versus unfavourable...
Author: Dr. Farid Azadian, University of OttawaReviewer: Dr. Kevin Imrie, Odette Cancer Centre (Sunnybrook Hospital)Learning ObjectivesAt the end of the self-assessment module, participants will be able to:Describe the treatment options for ALCL Describe the mechanism of action of Brentuximab vedotin Explain the efficacy and...
Authors: Dr. Thomas Kiebalo, Dr. Danyal Ladha, University of Toronto Reviewer: Dr. Hassan Sibai, Assistant Professor of Medicine, Faculty of Medicine, University of Toronto and Staff Physician, Division of Medical Hematology & Oncology, Princess Margaret Cancer CentreLearning objectives At the end of this self-assessment module, participants will be...
Case Author: Dr Brian HarnettCase Reviewer: Dr Donald ArnoldLearning Objectives:At the end of this self-assessment module, participants should be able to:Determine appropriate use of thrombopoietin receptor agonists in the setting of immune thrombocytopenia (ITP) and chronic liver disease. Determine clinical settings where certain thrombopoietin...
Author: Dr. Pallavi Ganguli, MDCM, Queen’s UniversityReviewer: Dr. Eugenia Piliotis, MD, MPH, Associate Dean, Queen’s University, Kingston General HospitalLearning objectives:At the end of this self-assessment module, participants should be able to:Understand the presentation of Mycosis fungoides Review appropriate investigations for the diagnosis of Mycosis...
Author: Dr. Stefan Jevtic (McMaster University) and Dr. Danyal Ladha (University of Toronto)Reviewer: Dr. Natasha Rupani, University of Toronto Learning Objectives At the end of the self-assessment module, learners will be able to: 1) Describe an approach to the diagnosis of heparin-induced thrombocytopenia 2) Identify risk factors and clinical...
Author: Dr. Yaqeen Abduallah, University of Manitoba Reviewer: Dr. Roopesh KansaraLearning ObjectivesAs the end of this self-assessment module, participants should be able to: 1. Describe the treatment options for patients with relapsed/refractory DLBCL 2. Described the mechanism of action of polatuzumab 3. Describe the most common adverse reactions of...